Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Cohn lab, within the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Research Center, is recruiting a talented postdoctoral fellow with expertise in HIV-biology and human immunology. The Cohn lab focuses on understanding the interaction between HIV and the human immune system. Our studies utilize human immunology, virology, and state-of-the-art technologies to study clinical samples from HIV-infected people. We focus our research on understanding the molecular, immunological and virologic forces that drive persistence of HIV-infected cells to inform cure strategies and identify novel drug targets.
The candidate will lead a project with the following goals:
Investigate the cellular and molecular mechanisms regulating clonal expansion of HIV-infected human CD4+ T cells to allow their lifelong persistence in vivo
Characterize the mechanisms which trigger latently infected CD4+ T cells to produce viremia after treatment interruption
A PhD in the field of immunology, virology, cell biology, or related field
A strong publication record and eligibility and desire to apply for future fellowships is important
The candidate must be experienced in essential techniques used to characterize human immune cells and must be comfortable working with BSL2+ pathogens from valuable and rare clinical samples. A candidate with experience in multi color flow cytometry, genomics and next generation sequencing methods is desired
A successful candidate will show curiosity and an initiative to learn new techniques, exceptional organizational and communication skills, be creative and innovative in their experimental design, and thrive working both independently while in a highly collaborative environment
A cover letter and research statement are required with your application
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and anti-racism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.